SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-020913
Filing Date
2023-04-27
Accepted
2023-04-27 16:04:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20006708x2_defa14a.htm DEFA14A 20020
2 ny20006708x2_nc1.jpg GRAPHIC 2042967
3 ny20006708x2_nc2.jpg GRAPHIC 1689567
  Complete submission text file 0001140361-23-020913.txt   4860459
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39329 | Film No.: 23856721
SIC: 2834 Pharmaceutical Preparations